Sugi Predict

Sugi Predict / Compounds / SCHEMBL2008289

SCHEMBL2008289

SCHEMBL2008289

Cc1ccc2c(c1)c(C(=O)c1nc(-c3ncccn3)no1)c(C)n2Cc1ccc(Cl)cc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ LMNA P02545 3/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CYP2C9 P11712 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ PTGDR2 Q9Y5Y4 6/20 0.37
▸ PTGS1 P23219 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ ALOX12 P18054 1/20 0.36
▸ AKR1B1 P15121 2/20 0.35
▸ VDR P11473 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2004856 0.93 LMNA (0.38) FAAHL3MBTL1LMNASMN1; SMN2CYP2C9
SCHEMBL2004316 0.92 LMNA (0.43) L3MBTL1LMNASMN1; SMN2CYP2C9MEN1
SCHEMBL2003201 0.92 GRM5 (0.41) FAAHL3MBTL1LMNASMN1; SMN2CYP2C9
SCHEMBL2004663 0.91 PLA2G2A (0.44) LMNACYP2C9MEN1CYP1A2CYP2C19
SCHEMBL2005482 0.90 L3MBTL1 (0.42) FAAHL3MBTL1LMNASMN1; SMN2CYP2C9
SCHEMBL2008177 0.89 TP53 (0.47) FAAHL3MBTL1LMNASMN1; SMN2CYP2C9
SCHEMBL1999914 0.88 GSK3B (0.42) FAAHL3MBTL1LMNASMN1; SMN2CYP2C9
SCHEMBL2005889 0.88 FAAH (0.40) FAAHL3MBTL1LMNASMN1; SMN2MEN1
SCHEMBL2004741 0.88 FAAH (0.38) FAAHL3MBTL1LMNASMN1; SMN2CYP2C9
SCHEMBL2007336 0.88 FAAH (0.40) FAAHL3MBTL1LMNASMN1; SMN2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 — — US disclosed
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 — — US disclosed
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 — — EP disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 — — US disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 — — US disclosed
US-7960544-B2 Useful indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2011-06-14 — — US disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 — — US disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 — — US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 — — US disclosed
US-20090264653-A1 USEFUL INDOLE COMPOUNDS IRONWOOD PHARMACEUTICALS, INC. 2009-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 FAAH 109/4885L3MBTL1 2079/4885LMNA 3450/4885
US-20090264653-A1 USEFUL INDOLE COMPOUNDS FAAH, FAAH2, AANAT FAAH 1/4885L3MBTL1 3423/4885LMNA 4536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.